Biostar Pharmaceuticals (Biostar Pharmaceuticals) EV-to-EBIT : 0.00 (As of Apr. 25, 2024)

Biostar Pharmaceuticals EV-to-EBIT Chart

Biostar Pharmaceuticals Annual Data
	Trend	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16
EV-to-EBIT		Get a 7-Day Free Trial					-0.25	8.65	12.14	-0.37	-3.48

Biostar Pharmaceuticals Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
EV-to-EBIT	Get a 7-Day Free Trial															-0.33	-3.48	-2.51	2.50	1.47

Competitive Comparison of Biostar Pharmaceuticals's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Biostar Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biostar Pharmaceuticals's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biostar Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biostar Pharmaceuticals's EV-to-EBIT falls into.

Biostar Pharmaceuticals EV-to-EBIT Calculation

Biostar Pharmaceuticals's EV-to-EBIT for today is calculated as:

Biostar Pharmaceuticals's current Enterprise Value is $0.00 Mil.
Biostar Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biostar Pharmaceuticals  (OTCPK:BSPM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Biostar Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2017 is calculated as:

Biostar Pharmaceuticals's Enterprise Value for the quarter that ended in Sep. 2017 was $5.57 Mil.
Biostar Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biostar Pharmaceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description